140 related articles for article (PubMed ID: 36618423)
1. Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation.
Zang C; Zhao Y; Liu G; Li K; Qin L; Zhang Y; Sun J; Wang Q; Ma L; Zhao P; Sun Y; Guo D; Yuan C; Dong T; Zhang Y
Front Immunol; 2022; 13():982578. PubMed ID: 36618423
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma.
Mizukoshi E; Yamashita T; Arai K; Sunagozaka H; Ueda T; Arihara F; Kagaya T; Yamashita T; Fushimi K; Kaneko S
Hepatology; 2013 Apr; 57(4):1448-57. PubMed ID: 23174905
[TBL] [Abstract][Full Text] [Related]
3. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
4. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
5. Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages.
Zang C; Zhao Y; Qin L; Liu G; Sun J; Li K; Zhao Y; Sheng S; Zhang H; He N; Zhao P; Wang Q; Li X; Peng Y; Dong T; Zhang Y
BMC Cancer; 2021 Sep; 21(1):1007. PubMed ID: 34496797
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
Thimme R; Neagu M; Boettler T; Neumann-Haefelin C; Kersting N; Geissler M; Makowiec F; Obermaier R; Hopt UT; Blum HE; Spangenberg HC
Hepatology; 2008 Dec; 48(6):1821-33. PubMed ID: 19003875
[TBL] [Abstract][Full Text] [Related]
7. Dynamic changes of phenotype and function of natural killer cells in peripheral blood before and after thermal ablation of hepatitis B associated hepatocellular carcinoma and their correlation with tumor recurrence.
Wang HY; Cui XW; Zhang YH; Chen Y; Lu NN; Bai L; Duan ZP
BMC Cancer; 2023 May; 23(1):486. PubMed ID: 37254046
[TBL] [Abstract][Full Text] [Related]
8. Association Between Expression Level of PD1 by Tumor-Infiltrating CD8
Kim HD; Song GW; Park S; Jung MK; Kim MH; Kang HJ; Yoo C; Yi K; Kim KH; Eo S; Moon DB; Hong SM; Ju YS; Shin EC; Hwang S; Park SH
Gastroenterology; 2018 Dec; 155(6):1936-1950.e17. PubMed ID: 30145359
[TBL] [Abstract][Full Text] [Related]
9. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
10. Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Hiroishi K; Eguchi J; Baba T; Shimazaki T; Ishii S; Hiraide A; Sakaki M; Doi H; Uozumi S; Omori R; Matsumura T; Yanagawa T; Ito T; Imawari M
J Gastroenterol; 2010 Apr; 45(4):451-8. PubMed ID: 19936602
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer.
Butterfield LH; Ribas A; Potter DM; Economou JS
Cancer Immunol Immunother; 2007 Dec; 56(12):1931-43. PubMed ID: 17522860
[TBL] [Abstract][Full Text] [Related]
12. Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models.
Lu X; Deng S; Xu J; Green BL; Zhang H; Cui G; Zhou Y; Zhang Y; Xu H; Zhang F; Mao R; Zhong S; Cramer T; Evert M; Calvisi DF; He Y; Liu C; Chen X
J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 37040183
[TBL] [Abstract][Full Text] [Related]
13. AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients.
Evdokimova VN; Liu Y; Potter DM; Butterfield LH
J Immunother; 2007; 30(4):425-37. PubMed ID: 17457217
[TBL] [Abstract][Full Text] [Related]
14. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
[TBL] [Abstract][Full Text] [Related]
15. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma.
Leuchte K; Staib E; Thelen M; Gödel P; Lechner A; Zentis P; Garcia-Marquez M; Waldschmidt D; Datta RR; Wahba R; Wybranski C; Zander T; Quaas A; Drebber U; Stippel DL; Bruns C; von Bergwelt-Baildon M; Wennhold K; Schlößer HA
Cancer Immunol Immunother; 2021 Apr; 70(4):893-907. PubMed ID: 33006650
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
17. Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinoma.
Flecken T; Schmidt N; Hild S; Gostick E; Drognitz O; Zeiser R; Schemmer P; Bruns H; Eiermann T; Price DA; Blum HE; Neumann-Haefelin C; Thimme R
Hepatology; 2014 Apr; 59(4):1415-26. PubMed ID: 24002931
[TBL] [Abstract][Full Text] [Related]
18. Potent induction of antitumor immunity by combining cryo-thermal ablation with immune checkpoint inhibitors in hepatocellular carcinoma.
Qian L; Xie L; Zhu Y; Huang C; Meng Z
Liver Int; 2024 Mar; 44(3):723-737. PubMed ID: 38111027
[TBL] [Abstract][Full Text] [Related]
19. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
[TBL] [Abstract][Full Text] [Related]
20. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]